N-Methylphthalimide-substituted novel benzimidazolium salts were synthesized under argon gas by using a Schlenk line technique. N,N-Dimethylformamide (DMF) was dried over P 4 O 10 .
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All 1 H and 13 C{ 1 H} NMR were performed in CDCl 3 and DMSO-d 6 on Bruker 300 or 400
MHz Ultra Shield NMR spectrometer at ambient temperature. Chemical shifts () are given in ppm relative to tetramethylsilane (TMS) as an internal reference. Coupling constants (J) are given in Hertz (Hz). 1 H NMR signals are labeled as singlet (s), triplet (t) and multiplet (m).
Gas chromatography (GC) and gas chromatography-mass spectrometry (Shimadzu, GC-MS-QP2010 Plus) were used in the catalytic experiments. GC analysis was undertaken using an Agilent 6890N Network GC System with a HP-5 column (column diameter 0.32 mm, column length 30 m, column filler size 0.25 m) and temperature range from −60 to 325 °C. The UVvis spectra of the PEPPSI Pd-NHC complexes were taken in DMSO (0.01 M and 0.001 M)
with a Shimadzu Pharmaspec UV-1700 spectrophotometer from 600 to 230 nm. A micro cuvette from Hellma with 1 cm path length was used for all UV-vis measurements with 2 nm slits. For high resolution mass spectrometry (HRMS), each sample (0.1 mg) was dissolved in methanol (1 mL) and injected at a rate of 150 μL/h by a Cole Palmer syringe pump into the mass spectrometer. Mass spectrometry was performed on a Bruker Apex Qe 7T Fourier
Transform ion cyclotron resonance mass spectrometer equipped with an ESI/MALDI dual source in positive ion ESI mode. Melting points (mp) were measured in glass capillary tubes with an Electrothermal-9200 apparatus. Elemental analyses were performed by using a CHNS-932 LECO device. The FTIR spectra of the compounds were recorded in the 450-4000 cm −1 region with a Shimadzu FTIR 8400 spectrophotometer.
Synthesis of novel compounds
General preparation of benzimidazolium salts 1-4
Benzimidazole (1 mmol) and potassium hydroxide (1 mmol) were dissolved in ethyl alcohol (60 mL). The alkyl halide (1 mmol) was slowly added after the obtained reaction mixture was stirred at room temperature for 1 h. 
General preparation of PEPPSI Pd-NHC complexes 5-8
The synthesis of PEPPSI Pd-NHC complexes in a 75 mL Schlenk tube was performed by the reaction of benzimidazolium salts (1 mmol), PdCl 2 (1 mmol) and K 2 CO 3 (5 mmol) as a base 
1,3-Bis(N-phthalimidomethyl)benzimidazolium bromide (3)
According to the same conditions and procedure as for 1, 3 was synthesized from 1-(Nphthalimidomethyl)benzimidazole (1.29 g, 1 mmol) and N-(bromomethyl)phthalimide (1.12 g, 1 mmol) in DMF (4 mL). 
1-(N-Phthalimidomethyl)-3-(2-morpholinoethyl)benzimidazolium bromide (4)
According to the same conditions and procedure as for 1, 4 was synthesized from 1-(2-morpholinoethyl)benzimidazole (1.14 g, 1 mmol) and N- (bromomethyl) 
Dichloro[1-(N-phthalimidomethyl)-3-benzylbenzimidazol-2-ylidene](3-chloropyridine)palladium(II) (5)
Compound 5 was synthesized using 1-(N-phthalimidomethyl)-3-benzylbenzimidazolium bromide (0.2 g, 1 mmol), PdCl 2 (0.079 g, 1 mmol) and K 2 CO 3 (0.31 g, 5 mmol) as a base in 3-chloropyridine (3 mL) at 80 °C for 16 h. 47, 111.79, 111.89, 123.62, 123.84, 123.90, 124.91, 128.06, 128.27, 128.41, 128.88, 131.98, 132.49, 133.68, 134.42, 134.48, 135.75, 137.80, 150.64 
Dichloro[1-(N-phthalimidomethyl)-3-(3-methylbenzyl)benzimidazol-2-ylidene](3-chloropyridine)palladium(II) (6)
Complex 6 111.91, 123.58, 123.69, 123.91, 124.91, 125.10, 128.70, 129.05, 131.98, 132.50, 133.69, 133.76, 134.50, 135.52, 135.72, 137.78, 137.87, 138.70, 150.18, 150.64 PdCl 2 (0.074 g, 1 mmol) in 3-chloropyridine (3 mL).
